Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2007

Open Access 01-09-2007 | Research

Genome-wide association with bone mass and geometry in the Framingham Heart Study

Authors: Douglas P Kiel, Serkalem Demissie, Josée Dupuis, Kathryn L Lunetta, Joanne M Murabito, David Karasik

Published in: BMC Medical Genetics | Special Issue 1/2007

Login to get access

Abstract

Background

Osteoporosis is characterized by low bone mass and compromised bone structure, heritable traits that contribute to fracture risk. There have been no genome-wide association and linkage studies for these traits using high-density genotyping platforms.

Methods

We used the Affymetrix 100K SNP GeneChip marker set in the Framingham Heart Study (FHS) to examine genetic associations with ten primary quantitative traits: bone mineral density (BMD), calcaneal ultrasound, and geometric indices of the hip. To test associations with multivariable-adjusted residual trait values, we used additive generalized estimating equation (GEE) and family-based association tests (FBAT) models within each sex as well as sexes combined. We evaluated 70,987 autosomal SNPs with genotypic call rates ≥80%, HWE p ≥ 0.001, and MAF ≥10% in up to 1141 phenotyped individuals (495 men and 646 women, mean age 62.5 yrs). Variance component linkage analysis was performed using 11,200 markers.

Results

Heritability estimates for all bone phenotypes were 30–66%. LOD scores ≥3.0 were found on chromosomes 15 (1.5 LOD confidence interval: 51,336,679–58,934,236 bp) and 22 (35,890,398–48,603,847 bp) for femoral shaft section modulus. The ten primary phenotypes had 12 associations with 100K SNPs in GEE models at p < 0.000001 and 2 associations in FBAT models at p < 0.000001. The 25 most significant p-values for GEE and FBAT were all less than 3.5 × 10-6 and 2.5 × 10-5, respectively. Of the 40 top SNPs with the greatest numbers of significantly associated BMD traits (including femoral neck, trochanter, and lumbar spine), one half to two-thirds were in or near genes that have not previously been studied for osteoporosis. Notably, pleiotropic associations between BMD and bone geometric traits were uncommon. Evidence for association (FBAT or GEE p < 0.05) was observed for several SNPs in candidate genes for osteoporosis, such as rs1801133 in MTHFR; rs1884052 and rs3778099 in ESR1; rs4988300 in LRP5; rs2189480 in VDR; rs2075555 in COLIA1; rs10519297 and rs2008691 in CYP19, as well as SNPs in PPARG (rs10510418 and rs2938392) and ANKH (rs2454873 and rs379016). All GEE, FBAT and linkage results are provided as an open-access results resource at http://​www.​ncbi.​nlm.​nih.​gov/​projects/​gap/​cgi-bin/​study.​cgi?​id=​phs000007.

Conclusion

The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.
Literature
1.
Klibanski A, Adams-Campbell L, Bassford T, Blair S, Boden S, Dickersin K, Gifford D, Glasse L, Goldring S, Hruska K, Johnson S, McCauley L, Russell W: Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001, 285 (6): 785-795. 10.1001/jama.285.6.785.CrossRef
2.
U. S. Department of Health and Human Services: Bone Health and Osteoporosis: A Report of the Surgeon General. 2004, U.S. Department of Health and Human Services, Office of the Surgeon General; Rockville, MD
3.
Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002, 359 (9319): 1761-1767. 10.1016/S0140-6736(02)08657-9.CrossRefPubMed
4.
Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures [see comments]. Bmj. 1996, 312 (7041): 1254-1259.PubMedCentralCrossRefPubMed
5.
Greenspan SL, Beck TJ, Resnick NM, Bhattacharya R, Parker RA: Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial. J Bone Miner Res. 2005, 20 (9): 1525-1532. 10.1359/JBMR.050508.CrossRefPubMed
6.
Uusi-Rasi K, Beck TJ, Semanick LM, Daphtary MM, Crans GG, Desaiah D, Harper KD: Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporos Int. 2006, 17 (4): 575-586. 10.1007/s00198-005-0028-3.CrossRefPubMed
7.
Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ: Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone. 2005, 36 (6): 948-958. 10.1016/j.bone.2005.03.003.CrossRefPubMed
8.
Arden NK, Baker J, Hogg C, Baan K, Spector TD: The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. Journal of Bone and Mineral Research. 1996, 11 (4): 530-534.CrossRefPubMed
9.
Gluer CC, Hans D: How to use ultrasound for risk assessment: a need for defining strategies. Osteoporos Int. 1999, 9 (3): 193-195. 10.1007/s001980050135.CrossRefPubMed
10.
Faulkner KG, Wacker WK, Barden HS, Simonelli C, Burke PK, Ragi S, Del Rio L: Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int. 2006, 17 (4): 593-599. 10.1007/s00198-005-0019-4.CrossRefPubMed
11.
Faulkner KG, Cummings SR, Black D, Palermo L, Gluer CC, Genant HK: Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res. 1993, 8 (10): 1211-1217.CrossRefPubMed
12.
Shen H, Recker RR, Deng HW: Molecular and genetic mechanisms of osteoporosis: implication for treatment. Curr Mol Med. 2003, 3 (8): 737-757. 10.2174/1566524033479375.CrossRefPubMed
13.
Ioannidis JP, Ng MY, Sham PC, Zintzaras E, Lewis CM, Deng HW, Econs MJ, Karasik D, Devoto M, Kammerer CM, Spector T, Andrew T, Cupples LA, Duncan EL, Foroud T, Kiel DP, Koller D, Langdahl B, Mitchell BD, Peacock M, Recker R, Shen H, Sol-Church K, Spotila LD, Uitterlinden AG, Wilson SG, Kung AW, Ralston SH: Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res. 2007, 22 (2): 173-183. 10.1359/jbmr.060806.PubMedCentralCrossRefPubMed
14.
Howard GM, Nguyen TV, Harris M, Kelly PJ, Eisman JA: Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res. 1998, 13 (8): 1318-1327. 10.1359/jbmr.1998.13.8.1318.CrossRefPubMed
15.
Karasik D, Myers RH, Hannan MT, Gagnon D, McLean RR, Cupples LA, Kiel DP: Mapping of quantitative ultrasound of the calcaneus bone to chromosome 1 by genome-wide linkage analysis. Osteoporos Int. 2002, 13 (10): 796-802. 10.1007/s001980200110.CrossRefPubMed
16.
Koller DL, Liu G, Econs MJ, Hui SL, Morin PA, Joslyn G, Rodriguez LA, Conneally PM, Christian JC, Johnston CC, Foroud T, Peacock M: Genome screen for quantitative trait loci underlying normal variation in femoral structure. Journal of Bone and Mineral Research. 2001, 16 (6): 985-991. 10.1359/jbmr.2001.16.6.985.CrossRefPubMed
17.
Peacock M, Koller DL, Lai D, Hui S, Foroud T, Econs MJ: Sex-specific quantitative trait loci contribute to normal variation in bone structure at the proximal femur in men. Bone. 2005, 37 (4): 467-473. 10.1016/j.bone.2005.05.005.PubMedCentralCrossRefPubMed
18.
Shen H, Long JR, Xiong DH, Liu YJ, Liu YZ, Xiao P, Zhao LJ, Dvornyk V, Zhang YY, Rocha-Sanchez S, Liu PY, Li JL, Deng HW: Mapping quantitative trait loci for cross-sectional geometry at the femoral neck. J Bone Miner Res. 2005, 20 (11): 1973-1982. 10.1359/JBMR.050715.CrossRefPubMed
19.
Xiong DH, Shen H, Xiao P, Guo YF, Long JR, Zhao LJ, Liu YZ, Deng HY, Li JL, Recker RR, Deng HW: Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis. J Bone Miner Res. 2006, 21 (3): 424-437. 10.1359/JBMR.051202.CrossRefPubMed
20.
Shen H, Liu Y, Liu P, Recker RR, Deng HW: Nonreplication in genetic studies of complex diseases--lessons learned from studies of osteoporosis and tentative remedies. J Bone Miner Res. 2005, 20 (3): 365-376. 10.1359/JBMR.041129.CrossRefPubMed
21.
Karasik D, Cupples LA, Hannan MT, Kiel DP: Age, gender, and body mass effects on quantitative trait loci for bone mineral density: the Framingham study. Bone. 2003, 33 (3): 308-316. 10.1016/S8756-3282(03)00173-X.CrossRefPubMed
22.
Karasik D, Myers RH, Cupples LA, Hannan MT, Gagnon DR, Herbert A, Kiel DP: Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: the Framingham Study. J Bone Miner Res. 2002, 17 (9): 1718-1727. 10.1359/jbmr.2002.17.9.1718.CrossRefPubMed
23.
Demissie S, Dupuis J, Cupples LA, Beck TJ, Kiel DP, Karasik D: Proximal hip geometry is linked to several chromosomal regions: Genome-wide linkage results from the Framingham Osteoporosis Study. Bone. 2007, 40 (3): 743-750. 10.1016/j.bone.2006.09.020.PubMedCentralCrossRefPubMed
24.
Ferrari SL, Karasik D, Liu J, Karamohamed S, Herbert AG, Cupples LA, Kiel DP: Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the framingham osteoporosis study. J Bone Miner Res. 2004, 19 (4): 552-559. 10.1359/JBMR.040103.CrossRefPubMed
25.
Shearman AM, Karasik D, Gruenthal KM, Demissie S, Cupples LA, Housman DE, Kiel DP: Estrogen receptor Beta polymorphisms are associated with bone mass in women and men: the Framingham study. J Bone Miner Res. 2004, 19 (5): 773-781. 10.1359/JBMR.0301258.CrossRefPubMed
26.
Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A: Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res. 2002, 17 (11): 2048-2060. 10.1359/jbmr.2002.17.11.2048.CrossRefPubMed
27.
Mann V, Ralston SH: Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone. 2003, 32 (6): 711-717. 10.1016/S8756-3282(03)00087-5.CrossRefPubMed
28.
Riancho JA, Valero C, Zarrabeitia MT: MTHFR polymorphism and bone mineral density: meta-analysis of published studies. Calcif Tissue Int. 2006, 79 (5): 289-293. 10.1007/s00223-006-0143-y.CrossRefPubMed
29.
Uitterlinden AG, Ralston SH, Brandi ML, Carey AH, Grinberg D, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Reeve J, Reid DM, Amedei A, Bassiti A, Bustamante M, Husted LB, Diez-Perez A, Dobnig H, Dunning AM, Enjuanes A, Fahrleitner-Pammer A, Fang Y, Karczmarewicz E, Kruk M, van Leeuwen JP, Mavilia C, van Meurs JB, Mangion J, McGuigan FE, Pols HA, Renner W, Rivadeneira F, van Schoor NM, Scollen S, Sherlock RE, Ioannidis JP: The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006, 145 (4): 255-264.CrossRefPubMed
30.
Cupples L, Arruda H, Benjamin E, D'Agostino R, Demissie S, DeStefano A, Dupuis J, Falls K, Fox C, Gottlieb D, Govindaraju D, Heard-Costa N, Hwang S, Kathiresan S, Kiel D, Laramie J, Larson M, Levy D, Lunetta K, Mailman M, Manning A, Meigs J, Murabito J, Newton-Cheh C, O'Connor G, O'Donnell C, Pandey M, Seshadri S, Vasan R, Wilk J, Wolf P, Yang Q, Atwood L: The Framingham Heart Study 100K SNP genome-wide association study resource: Overview of 17 phenotype working group reports. BMC Med Genet. 2007, 8 (Suppl 1): S1-PubMedCentralCrossRefPubMed
31.
Karasik D, Cupples LA, Hannan MT, Kiel DP: Genome screen for a combined bone phenotype using principal component analysis: the Framingham study. Bone. 2004, 34 (3): 547-556. 10.1016/j.bone.2003.11.017.CrossRefPubMed
32.
McLean RR, Hannan MT, Epstein BE, Bouxsein ML, Cupples LA, Murabito J, Kiel DP: Elderly cohort study subjects unable to return for follow-up have lower bone mass than those who can return. Am J Epidemiol. 2000, 151 (7): 689-692.CrossRefPubMed
33.
Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP: Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000, 15 (4): 710-720. 10.1359/jbmr.2000.15.4.710.CrossRefPubMed
34.
Khoo BC, Beck TJ, Qiao QH, Parakh P, Semanick L, Prince RL, Singer KP, Price RI: In vivo short-term precision of hip structure analysis variables in comparison with bone mineral density using paired dual-energy X-ray absorptiometry scans from multi-center clinical trials. Bone. 2005, 37 (1): 112-121. 10.1016/j.bone.2005.03.007.CrossRefPubMed
35.
Blangero J, Williams JT, Almasy L: Robust LOD scores for variance component-based linkage analysis. Genet Epidemiol. 2000, 19 (Suppl 1): S8-14. 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y.CrossRefPubMed
36.
Lange C, Silverman EK, Xu X, Weiss ST, Laird NM: A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics. 2003, 4 (2): 195-206. 10.1093/biostatistics/4.2.195.CrossRefPubMed
37.
38.
McLean RR, Karasik D, Selhub J, Tucker KL, Ordovas JM, Russo GT, Cupples LA, Jacques PF, Kiel DP: Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res. 2004, 19 (3): 410-418. 10.1359/JBMR.0301261.CrossRefPubMed
39.
Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L: Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone. 2005, 36 (3): 577-583. 10.1016/j.bone.2004.12.014.CrossRefPubMed
40.
Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, Conneally PM, Hui SL, Johnston CC, Peacock M, Foroud T, Econs MJ: Contribution of the LRP5 Gene to Normal Variation in Peak BMD in Women. J Bone Miner Res. 2005, 20 (1): 75-80. 10.1359/jbmr.2005.20.1.75.CrossRefPubMed
41.
Kiel DP, Ferrari SL, Cupples LA, Karasik D, Manen D, Imamovic A, Herbert AG, Dupuis J: Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone. 2007, 40 (3): 587-596. 10.1016/j.bone.2006.09.029.PubMedCentralCrossRefPubMed
42.
Schulze TG, McMahon FJ: Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered. 2004, 58 (3–4): 131-138. 10.1159/000083539.CrossRefPubMed
43.
Clark AG, Boerwinkle E, Hixson J, Sing CF: Determinants of the success of whole-genome association testing. Genome Res. 2005, 15 (11): 1463-1467. 10.1101/gr.4244005.CrossRefPubMed
44.
Nicolae DL, Wen X, Voight BF, Cox NJ: Coverage and characteristics of the Affymetrix GeneChip Human Mapping 100K SNP set. PLoS Genet. 2006, 2 (5): e67-10.1371/journal.pgen.0020067.PubMedCentralCrossRefPubMed
45.
Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP, Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG: Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. Jama. 2004, 292 (17): 2105-2114. 10.1001/jama.292.17.2105.CrossRefPubMed
46.
Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE: Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet. 2004, 74 (5): 866-875. 10.1086/420771.PubMedCentralCrossRefPubMed
47.
Lorentzon M, Swanson C, Eriksson AL, Mellstrom D, Ohlsson C: Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study. J Bone Miner Res. 2006, 21 (2): 332-339. 10.1359/JBMR.051026.CrossRefPubMed
48.
Yang TL, Zhao LJ, Liu YJ, Liu JF, Recker RR, Deng HW: Genetic and environmental correlations of bone mineral density at different skeletal sites in females and males. Calcif Tissue Int. 2006, 78 (4): 212-217. 10.1007/s00223-005-0267-5.CrossRefPubMed
49.
Enjuanes A, Garcia-Giralt N, Supervia A, Nogues X, Ruiz-Gaspa S, Bustamante M, Mellibovsky L, Grinberg D, Balcells S, Diez-Perez A: A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. Bone. 2006, 38 (5): 738-743. 10.1016/j.bone.2005.10.010.CrossRefPubMed
50.
Garcia-Giralt N, Nogues X, Enjuanes A, Puig J, Mellibovsky L, Bay-Jensen A, Carreras R, Balcells S, Diez-Perez A, Grinberg D: Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density. J Bone Miner Res. 2002, 17 (3): 384-393. 10.1359/jbmr.2002.17.3.384.CrossRefPubMed
51.
Garcia-Giralt N, Enjuanes A, Bustamante M, Mellibovsky L, Nogues X, Carreras R, Diez-Perez A, Grinberg D, Balcells S: In vitro functional assay of alleles and haplotypes of two COL1A1-promoter SNPs. Bone. 2005, 36: 902-908. 10.1016/j.bone.2004.12.012.CrossRefPubMed
52.
Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH: Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet. 1996, 14 (2): 203-205. 10.1038/ng1096-203.CrossRefPubMed
Metadata
Title
Genome-wide association with bone mass and geometry in the Framingham Heart Study
Authors
Douglas P Kiel
Serkalem Demissie
Josée Dupuis
Kathryn L Lunetta
Joanne M Murabito
David Karasik
Publication date
01-09-2007
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue Special Issue 1/2007
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-8-S1-S14

Other articles of this Special Issue 1/2007

BMC Medical Genetics 1/2007 Go to the issue

Introduction

The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports

Research

Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study

Research

Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study

Research

A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study

Research

Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study

Research

A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study